FDA Allows New Remedy For Arthritis – New York Times

FDA Allows New Remedy For Arthritis
New York Times
By AP WASHINGTON (AP) – The Food and Drug Administration approved a potential blockbuster drug from Johnson & Johnson on Friday that fights three forms of arthritis caused by immune-system disorders.
FDA OKs Simponi for Rheumatoid Arthritis WebMD
Simponi Approved for Immune-Related Arthritis U.S. News & World Report
The Associated Press - Bloomberg - Attorney at Law - FierceBiotech
all 95 news articles